[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Page 79937]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22437]
[[Page 79937]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Partially Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Cancer Institute.
The meeting will be partially open to the public as indicated
below, with attendance limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The open session
will be videocast and can be accessed from the NIH Videocasting and
Podcasting website (http://videocast.nih.gov/).
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual intramural programs and projects conducted by
the National Cancer Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: November 4, 2024.
Open: 10:00 a.m. to 10:30 a.m.
Agenda: Remarks from the NCI Director.
Closed: 10:30 a.m. to 4:40 p.m.
Agenda: Personnel qualifications and performance, and competence
of individual investigators.
Address: National Institutes of Health, Building 31, C Wing, 6th
Floor, Conference Room C, 9000 Rockville Pike, Bethesda, MD 20892
(In-Person and Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D., Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, 9609 Medical Center Drive, Room 3W414,
Bethesda, MD 20892, 240-276-5665, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsc/index.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 25, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-22437 Filed 9-30-24; 8:45 am]
BILLING CODE 4140-01-P